The number of HLA confirmatory tests during unrelated donor search as a driver for the evaluation of back-up haploidentical donor(s).


Journal

Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis
ISSN: 1473-0502
Titre abrégé: Transfus Apher Sci
Pays: England
ID NLM: 101095653

Informations de publication

Date de publication:
Aug 2020
Historique:
received: 21 12 2019
revised: 01 03 2020
accepted: 01 03 2020
pubmed: 12 4 2020
medline: 9 6 2021
entrez: 12 4 2020
Statut: ppublish

Résumé

the identification of a suitable donor in an appropriate timing represents a crucial step in the preparation of allogeneic stem cell transplantation (HSCT). At our Institution, for patients lacking an HLA-identical sibling, a haploidentical donor is considered in the absence of a 10/10-matched or a one-locus HLA-mismatched unrelated donor (UD), but the optimal timing of work-up of potential familiar haploidentical donor(s) by the Apheresis Team is actually unknown. we analyzed here n = 167 UD searches launched at our Hospital between July 2013 and July 2018 and looked for any correlation between the number of HLA confirmatory tests received and the final type of donor selected for HSCT, in an attempt to identify those situations where prompt evaluation of haploidentical donor(s) is warranted. a total of n = 117 transplants were performed and haploidentical HSCTs were n = 16 (14 %). In n = 93 cases (56 %) the number of HLA confirmatory tests received were two; they were one, zero and three for n = 52, n = 14 and n = 8 patients, respectively. Only 5 % of haploidentical donors were used when two confirmation test samples were received whereas this percentage rises to 17 % when only one sample reached the HLA lab. When no confirmation tests were available, haploidentical transplant occurred in 100 % of cases. besides the situations with no HLA confirmation tests, the evaluation of any haploidentical donor(s) should be promptly started also when only one HLA confirmatory test is received, in order to optimise the potential work-up process and avoid delay in transplantation.

Identifiants

pubmed: 32276862
pii: S1473-0502(20)30056-2
doi: 10.1016/j.transci.2020.102766
pii:
doi:

Types de publication

Journal Article

Langues

eng

Pagination

102766

Informations de copyright

Copyright © 2020 Elsevier Ltd. All rights reserved.

Auteurs

Roberto Crocchiolo (R)

ASST Grande Ospedale Metropolitano Niguarda, Milano. Piazza Dell'Ospedale Maggiore 3, 20162, Milano, Italy. Electronic address: roberto.crocchiolo@ospedaleniguarda.it.

Giorgia Cornacchini (G)

ASST Grande Ospedale Metropolitano Niguarda, Milano. Piazza Dell'Ospedale Maggiore 3, 20162, Milano, Italy.

Giuliana Lando (G)

ASST Grande Ospedale Metropolitano Niguarda, Milano. Piazza Dell'Ospedale Maggiore 3, 20162, Milano, Italy.

Arianna Coviello (A)

ASST Grande Ospedale Metropolitano Niguarda, Milano. Piazza Dell'Ospedale Maggiore 3, 20162, Milano, Italy.

Irene Cuppari (I)

ASST Grande Ospedale Metropolitano Niguarda, Milano. Piazza Dell'Ospedale Maggiore 3, 20162, Milano, Italy.

Elisabetta Volpato (E)

ASST Grande Ospedale Metropolitano Niguarda, Milano. Piazza Dell'Ospedale Maggiore 3, 20162, Milano, Italy.

Maria Teresa Pugliano (MT)

ASST Grande Ospedale Metropolitano Niguarda, Milano. Piazza Dell'Ospedale Maggiore 3, 20162, Milano, Italy.

Giovanni Grillo (G)

ASST Grande Ospedale Metropolitano Niguarda, Milano. Piazza Dell'Ospedale Maggiore 3, 20162, Milano, Italy.

Elisa Zucchetti (E)

ASST Grande Ospedale Metropolitano Niguarda, Milano. Piazza Dell'Ospedale Maggiore 3, 20162, Milano, Italy.

Silvano Rossini (S)

ASST Grande Ospedale Metropolitano Niguarda, Milano. Piazza Dell'Ospedale Maggiore 3, 20162, Milano, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH